IMC Chicago’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2M Buy
104,300
+23,600
+29% +$1.55M ﹤0.01% 1463
2026
Q1
$638K Buy
+80,700
New +$1.3M ﹤0.01% 3762
2025
Q2
Sell
-2,444
Closed -$265K 3271
2025
Q1
$265K Sell
2,444
-1,788
-42% -$156K ﹤0.01% 2965
2024
Q4
$201K Buy
4,232
+424
+11% +$25.6K ﹤0.01% 3103
2024
Q3
$374K Buy
3,808
+1,708
+81% +$221K ﹤0.01% 2544
2024
Q2
$343K Buy
+2,100
New +$299K ﹤0.01% 2441

Other funds holding AGL

IMC Chicago's AGL Position: Q2 2026 in Review

IMC Chicago opened a new position in Agilon Health (AGL) in Q2 2026: 9,379 shares worth $1.01M. The stake represents ﹤0.01% of the portfolio and ranks #3853 among its holdings. This is a return to the name: IMC Chicago previously reported a position in AGL as recently as Q3 2024.

IMC Chicago first reported a position in AGL in Q3 2024 and has held it in 2 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • IMC Chicago held 9,379 shares of Agilon Health worth $1.01M as of Q2 2026.
  • Agilon Health was a new IMC Chicago position in Q2 2026.
  • Agilon Health made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #3853 holding.
  • IMC Chicago first reported a position in Agilon Health in Q3 2024 and has held it in 2 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.